This inventor holds 1 USPTO granted patent. Top assignee: Heraeus Medical Gmbh. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Harro Antheunis: Innovator in Artificial Cartilage Technology
Introduction
Harro Antheunis is a notable inventor based in Beek-Ubbergen, Netherlands. He has made significant contributions to the field of medical technology, particularly in the development of artificial cartilage solutions. His innovative work has led to the creation of a unique patent that addresses critical needs in the medical industry.
Latest Patents
Harro Antheunis holds a patent for a two-component system for the in situ preparation of an artificial cartilage. This invention involves a polymer network that is created by polymerizing acrylate monomers in the presence of a redox initiator couple. The system consists of two containers: one containing an activator and the other containing an initiator. The combined water content in both containers is at least 50 wt. %, based on the total weight of the contents. This innovative approach aims to enhance the effectiveness of artificial cartilage applications.
Career Highlights
Harro Antheunis is associated with Heraeus Medical GmbH, a company known for its advancements in medical technology. His work at Heraeus Medical has allowed him to focus on developing solutions that improve patient outcomes in orthopedic applications. His dedication to innovation is evident in his patent and ongoing research efforts.
Collaborations
Harro collaborates with Christian Wahnes, who is also involved in the development of medical technologies. Their partnership exemplifies the importance of teamwork in advancing innovative solutions in the healthcare sector.
Conclusion
Harro Antheunis is a distinguished inventor whose work in artificial cartilage technology has the potential to transform medical treatments. His patent reflects a commitment to innovation and improving patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
